Mohsin Ali, MD
Retina Specialist · Greenbelt, MDNPI 1063855534
Payments from drug & device makers
Across 160 payments — averaging $95.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$8K
- Alimera Sciences, Inc.$2K
- Notal Vision, Inc.$1K
- Dutch Ophthalmic, USA$928
- Genentech USA, Inc.$581
- Apellis Pharmaceuticals, Inc.$298
- plus $2K from 17 others
What the payments were for
- Consulting fees$5,70041%
- Travel & lodging$3,85728%
- Food & beverage$4,33031%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 26 | $7,561 |
| Alimera Sciences, Inc. | 8 | $2,190 |
| Notal Vision, Inc. | 43 | $1,380 |
| Dutch Ophthalmic, USA | 2 | $928 |
| Genentech USA, Inc. | 21 | $581 |
| Apellis Pharmaceuticals, Inc. | 7 | $298 |
| Astellas Pharma US Inc | 9 | $256 |
| Alcon | 2 | $235 |
| Regeneron Healthcare Solutions, Inc. | 7 | $225 |
| Eyepoint US, Inc. | 7 | $181 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $171 |
| ANI Pharmaceuticals, Inc. | 3 | $169 |
| Rxsight Inc | 2 | $151 |
| Coopervision Inc. | 1 | $143 |
| Bausch & Lomb Americas Inc. | 7 | $140 |
| Biotissue Holdings Inc. | 1 | $137 |
| Tarsus Pharmaceuticals, Inc. | 1 | $136 |
| Dompe US, Inc. | 1 | $125 |
| Genentech, Inc. | 2 | $81 |
| Sandoz | 2 | $57 |
| Novartis | 3 | $55 |
| Coherus Oncology, Inc. | 2 | $47 |
| Mallinckrodt Hospital Products Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OZURDEX$6,975
- Iluvien$2,090
- EVA, combined machine$840
- TISSUEBLUE$840
- MiSight Contact Lens$143
- Prokera$137
- XDEMVY$136
- Oxervate$125
- ReSTOR$120
- TRYPTYR$115
- STELLARIS PC$115
- Syfovre$113
- PURIFIED CORTROPHIN GEL$112
- OCREVUS$108
How this compares
$15,267 in reported general payments places this provider in the 75th percentile of 47 retina specialist providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 58 | $2,982 |
| Ketorolac Tromethamine | 44 | $872 |
| Ofloxacin | 24 | $453 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 19 | $397 |
| Brimonidine Tartrate | 11 | $381 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 24 | $262 |
| ErythromycinErythromycin Base | 20 | $203 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Greenbelt
- Joshua LevinsonGreenbelt$67K
- Reginald SandersGreenbelt$24K
- Jason HuangGreenbelt$4K
- Mariam MathaiGreenbelt$4K
- Sneha PadidamGreenbelt$4K
- Collin OhningGreenbelt$1K
- Geoffrey KaplanGreenbelt$792
- Adam GerstenblithHagerstown$8.6M
- Michael LaiChevy Chase$1.6M
- Brian DoChevy Chase$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.